Jonas Grossman - 01 Feb 2022 Form 4 Insider Report for Renovacor, Inc.

Role: Director
Signature: /s/ Joseph Carroll, Attorney-in-fact
Issuer symbol: N/A
Transactions as of: 01 Feb 2022
Net transactions value: $0
Form type: 4
Filing time: 03 Feb 2022, 19:55:57 UTC
Previous filing: 30 Sep 2021
Next filing: 31 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCOR	Common Stock	Other	$0	+40,000		$0.000000	40,000	01 Feb 2022	Direct	F1
holding	RCOR	Common Stock						1,605,661	01 Feb 2022	See footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock distributed to the Reporting Person from Chardan Healthcare Investments LLC for no consideration.
F2	Represents shares of common stock held by Chardan Investments 2, LLC. The Reporting Person is the Managing Member of Chardan Investments 2, LLC and may be deemed to have beneficial ownership of the common stock held directly by Chardan Investments 2, LLC. The Reporting Person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.

Content

Represents shares of common stock distributed to the Reporting Person from Chardan Healthcare Investments LLC for no consideration.

Represents shares of common stock held by Chardan Investments 2, LLC. The Reporting Person is the Managing Member of Chardan Investments 2, LLC and may be deemed to have beneficial ownership of the common stock held directly by Chardan Investments 2, LLC. The Reporting Person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.